Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

Atlantic Lithium progressing Ewoyaa despite mining lease delays

(Sharecast News) - Atlantic Lithium reported significant milestones in advancing the Ewoyaa Lithium Project in Ghana in an update on Friday, despite ongoing delays in the ratification of the project's mining lease. The AIM-traded company, which was holding its annual general meeting, said key achievements since the grant of the mining lease in October last year included securing the Environmental Protection Agency permit, mine operating permit, and land use certificate.

It also completed Feldspar and Downstream Conversion Studies, and successfully listed its shares on the Ghana Stock Exchange.

However, the final ratification of the mining lease had been delayed by political challenges ahead of Ghana's upcoming elections.

In response to the delays and weaker lithium prices, Atlantic Lithium said it had implemented significant cost reductions, including workforce cuts, to prioritise critical project activities.

The challenges had also affected funding progress, but the company remained firm in negotiating favorable terms for its offtake agreements.

Atlantic Lithium said it was still attracting demand for Ewoyaa's product, and expected to secure the necessary funding to cover its share of development costs.

Notable partnerships, including support from the Minerals Income Investment Fund (MIIF) and Assore, were said to have been pivotal.

MIIF completed a $5m subscription in January and was expected to finalise a project-level investment following permitting completion.

Assore meanwhile also led a successful AUD 10m (£5.12m) equity placement in October, enabling key project advancements.

Atlantic said it was focussed on optimising its definitive feasibility study, awarding key contracts, and preparing for a final investment decision (FID).

Despite current market pressures, the company emphasised the project's low-cost profile and strategic location, which positioned Ewoyaa competitively for rapid development once lithium prices recovered.

"We remain confident in the significant long-term demand for lithium as EV adoption continues at pace around the world and expect the current oversupply to be absorbed in the near-medium term," said chief executive officer Keith Muller.

"As we push forward towards shovel readiness, we, therefore, believe that Ewoyaa can be among the fastest out of the blocks as prices recover.

"Notwithstanding ratification of the mining lease, the year ahead presents itself as a hugely important period for the company."

Muller said key milestones included achieving final investment decision, the completion of remaining operational activities required to achieve shovel-readiness, the award of key project contracts and breaking ground itself.

At 1430 GMT, shares in Atlantic Lithium were down 2.05% at 11.96p.

Reporting by Josh White for Sharecast.com.

Share this article

Related Sharecast Articles

Catenai extends convertible loan note facility with Klarian
(Sharecast News) - Digital media and technology specialist Catenai announced an extension to the redemption date of its £0.45m unsecured convertible loan note (CLN) facility with Klarian on Monday.
Eden Research revenue rises, losses set to widen
(Sharecast News) - Sustainable biopesticide and biocontrol technology specialist Eden Research reported significant revenue growth for the year ended 31 December on Monday, alongside a positive outlook for 2025.
Science Group set for another record adjusted operating profit
(Sharecast News) - Science Group said in an update on Monday that trading for the year ended 31 December was expected to deliver another record year of adjusted operating profit, in line with or slightly exceeding board expectations.
hVIVO completes pilot study for hMPV challenge model
(Sharecast News) - Contract research organisation and human challenge trial specialist hVIVO announced the successful completion of a pilot characterisation study for its human metapneumovirus (hMPV) challenge model on Monday.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.